MIST - Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07 revenue of $1.5M November, 10 2022 09:10 AM Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals press release ( NASDAQ: MIST ): Q3 GAAP EPS of -$0.34 beats by $0.07 . Revenue of $1.5M (-98.8% Y/Y). For further details see: Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M